Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Selvita Acquires License for Medicines Discovery Catapult’s Patented Target Engagement Technology

Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and patented by Medicines Discovery Catapult (MDC) to help identify and prioritise drug candidates faster.

MDC’s Chemical Protein Stability Assay (CPSA) is a distinctive technology used to assess target engagement. It can be applied at every step of the drug discovery process to support drug development, screening, and optimisation.

Business Continuity Planning Cheat Sheet for Labs

When it comes to unforeseen research disruptions, the most successful lab operations professionals hope for “if” but plan for “when.” Yet, a survey found that only 51% of businesses have continuity plans. Business continuity plans (BCPs) ensure labs can maintain critical functions, quickly resume normal operations, and prevent the loss of valuable research in the event of interruptions. This guide explores why and how to create a business continuity plan for your laboratory.

Maxion Therapeutics doubles R&D space at Unity Campus after £58 million Series A fundraise

•    Maxion Therapeutics expands its Cambridge headquarters and doubles the size of its offices and laboratory space
•    Howard Group provides tailored real estate solution to support the biotech’s growth

Cambridge, 20th May 2025: Leading regional property investor and developer Howard Group, is delighted to announce that pioneering biotechnology company Maxion Therapeutics has more than doubled its footprint at Unity Campus.

Breaking New Ground in Stem Cell Therapy: Creative Biolabs Introduces Advanced iPSC Solutions

Creative Biolabs is at the forefront of creating stem cell therapy, working with researchers to make new scientific advancements.

Induced pluripotent stem cells (iPSCs) contain the unprecedented possibility of differentiating into almost every cell in the body, which holds vast avenues for disease studying and developing novel therapies. Nonetheless, iPSC-based cell therapy is presently problematic. Issues like low reprogramming efficiency, genomic instability, risk of tumorigenicity, and failure in controlling differentiation encompass significant setbacks.

Equipping Business Leaders: Geopolitical Risks & Economic Strategies (2 Available Dates)

MHA and Baker Tilly are hosting a briefing led by Professor Joe Nellis (Cranfield Business School), focusing on the intersection of economic trends and geopolitical risks currently impacting the UK. This short briefing will provide valuable up-to-date insights for fiscal planning, including:

- Navigating and prioritising key risks
- Capitalising on the right investments
- Optimising your business model

ARECOR ESTABLISHES PARTNERSHIP WITH SKYE BIOSCIENCE TO DEVELOP ENHANCED FORMULATION OF OBESITY CANDIDATE NIMACIMAB

Arecor Therapeutics plc
(“Arecor” or the “Company”)

ARECOR ESTABLISHES PARTNERSHIP WITH SKYE BIOSCIENCE TO DEVELOP ENHANCED FORMULATION OF OBESITY CANDIDATE NIMACIMAB

- Proprietary formulation technology being applied to potentially enhance properties of nimacimab

Subscribe to